Pfizer to Pursue Lyme Disease Vaccine Approval Despite Late-Stage Trial Setback Pfizer announced on Monday it will seek regulatory approval for its investigational Lyme disease vaccine, despite the fact that …
Tag:
iShares U.S. Pharmaceuticals ETF
-
-
Lilly’s Retatrutide Shows Promise in Type 2 Diabetes Trial, Delivering Significant Weight Loss Eli Lilly and Company announced positive topline results from the TRANSCEND-T2D-1 Phase 3 clinical trial evaluating retatrutide, …
-
Eli Lilly Launches Zepbound KwikPen for More Convenient Weight Management Eli Lilly and Company announced on Monday the availability of a new delivery option for its blockbuster obesity drug, Zepbound …
-
Here’s a revised news summary based on the provided headlines, with verification and updates as of today, February 5, 2024. I’ve focused on providing current context and accurate details, discarding …